Insider Selling: DocuSign, Inc. (NASDAQ:DOCU) Insider Sells 1,800 Shares of Stock

DocuSign, Inc. (NASDAQ:DOCUGet Free Report) insider James P. Shaughnessy sold 1,800 shares of DocuSign stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $57.50, for a total value of $103,500.00. Following the completion of the sale, the insider now directly owns 46,503 shares of the company’s stock, valued at $2,673,922.50. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

DocuSign Trading Up 3.3 %

NASDAQ:DOCU opened at $60.55 on Thursday. DocuSign, Inc. has a 1 year low of $38.11 and a 1 year high of $64.76. The stock has a market cap of $12.44 billion, a price-to-earnings ratio of 168.20, a PEG ratio of 5.09 and a beta of 0.89. The stock has a 50-day moving average price of $55.66 and a two-hundred day moving average price of $50.76.

DocuSign (NASDAQ:DOCUGet Free Report) last posted its earnings results on Thursday, March 7th. The company reported $0.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.09 by $0.06. The firm had revenue of $712.39 million during the quarter, compared to analysts’ expectations of $698.05 million. DocuSign had a return on equity of 13.91% and a net margin of 2.68%. Sell-side analysts forecast that DocuSign, Inc. will post 0.86 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts recently commented on DOCU shares. TheStreet raised DocuSign from a “d+” rating to a “c-” rating in a research note on Tuesday, December 19th. Morgan Stanley raised DocuSign from an “underweight” rating to an “equal weight” rating and lifted their price objective for the stock from $49.00 to $64.00 in a research note on Tuesday, January 16th. Piper Sandler decreased their price objective on DocuSign from $57.00 to $50.00 and set a “neutral” rating for the company in a research note on Friday, December 8th. Wells Fargo & Company decreased their price objective on DocuSign from $55.00 to $45.00 and set an “underweight” rating for the company in a research note on Monday, February 5th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $84.00 price objective on shares of DocuSign in a research note on Monday, January 22nd. Three analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, DocuSign has a consensus rating of “Hold” and a consensus target price of $58.33.

Get Our Latest Report on DocuSign

Institutional Trading of DocuSign

Institutional investors have recently modified their holdings of the company. Nelson Van Denburg & Campbell Wealth Management Group LLC lifted its holdings in shares of DocuSign by 440.0% in the first quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 270 shares of the company’s stock valued at $28,000 after purchasing an additional 220 shares in the last quarter. Capital Analysts LLC lifted its holdings in shares of DocuSign by 781.7% in the fourth quarter. Capital Analysts LLC now owns 529 shares of the company’s stock valued at $31,000 after purchasing an additional 469 shares in the last quarter. BluePath Capital Management LLC bought a new stake in shares of DocuSign in the third quarter valued at about $32,000. McGlone Suttner Wealth Management Inc. bought a new stake in shares of DocuSign in the fourth quarter valued at about $32,000. Finally, Virtus Fund Advisers LLC bought a new stake in shares of DocuSign in the fourth quarter valued at about $33,000. 77.64% of the stock is currently owned by institutional investors.

DocuSign Company Profile

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides DocuSign e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

See Also

Insider Buying and Selling by Quarter for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.